| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.069 | 0.2 |